Skip to main content
OpenTrials
Completed

NCT Number: NCT04755634

Shafer Width and Girth: The Use of Injectable Fillers for Penile Enhancement

Injectable filler will be performed by Principal Investigator under sterile conditions for the enhancement of girth and surface area of the penis.

Completed

Looking for future studies?

Notify Me

Key information

Age range

21 year–65 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Shafer Clinic Fifth Avenue

New York, 10017, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy males,
  • 21 to 65 years of age,
  • Seeking enhancement of their penile width and girth.

Exclusion criteria

  • Patient with a history of psychological or psychiatric illness,
  • Congenital or acquired penile malformation,
  • Previous plastic surgery or non-invasive treatments of their penis,
  • Any chronic disease such as vascular disorder, urological disorder, myocardial infarction, hypertension, cerebrovascular accident or coagulopathy.
  • Patients with a history of allergic reactions to hyaluronic acid derivatives
  • Individuals with penises measured less than 6 cm in length in the flaccid position
  • Individuals with penises greater than 12.5 cm in length in the flaccid position.
  • Individuals with uncircumcised penises

Treatment and study plan

Hyaluronic Acid

Device

Injectable

Primary outcomes

  1. Increase in penile width and girth

    Time frame: 1 year

    Three-dimensional (3D) surface images taken by a digital stereophotogrammetry system at the baseline will be compared to the images taken at 1 year post-treatment follow up.

Secondary outcomes

  1. Duration of increase in penile width and girth

    Time frame: 1 year

    For how long duration the treatment will produce a measurable difference in penile size.

Sponsors and collaborators

Lead sponsor

Shafer Clinic Fifth Avenue

Network

Registry information

Important dates

Study start
2021
Primary completion
2024
Study completion
2024
First posted
Feb 16, 2021
Registry last updated
May 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.